The presence of type 2 diabetes is considered a risk factor for the development of chronic kidney disease (CKD). Simple screening measures based on blood and urine samples can detect CKD at an early stage. This is becoming increasingly important, as the progression of kidney failure – especially in the early stages – can now be effectively delayed with medication.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- Nephrologie-Special
Related Topics
You May Also Like
- HFpEF 2025
Precision medicine and phenotypes
- Myelofibrosis
New treatment options for myelofibrosis patients with a high risk of anemia?
- Chronic insomnia in adults: Guideline recommendations
CBT-i as first choice – pharmacotherapy as secondary intervention
- COPD therapy
Drug therapy – Update 2025
- Pulmonary hypertension
PH and lung diseases
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- Focus on prevention
Colorectal cancer screening – an update
- Chronic hand eczema